.svg)
This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making changes to your health routine.
Quick answer: HOMA-IR is a calculated score derived from fasting insulin and fasting glucose that estimates insulin resistance. A score below 2.0 is generally considered within the normal range in most clinical contexts, while scores above 2.5 to 3.0 may suggest increasing insulin resistance. Because HOMA-IR is a derived value rather than a direct measurement, it should be interpreted alongside other metabolic markers and in consultation with a qualified provider.
What is HOMA-IR and Why Does it Matter?
Insulin resistance is one of the most consequential metabolic shifts that can occur before type 2 diabetes develops — and one of the hardest to detect from symptoms alone. The Homeostatic Model Assessment of Insulin Resistance, or HOMA-IR, is a calculated index that uses two routine blood values — fasting insulin and fasting glucose — to estimate how well the body's cells are responding to insulin signals.
The formula is straightforward: HOMA-IR = (fasting insulin in mIU/L x fasting glucose in mg/dL) / 405. When insulin sensitivity is normal, the pancreas produces modest amounts of insulin and blood glucose stays stable. As insulin resistance develops, the pancreas compensates by secreting progressively more insulin to achieve the same glucose-lowering effect. HOMA-IR captures this compensatory elevation before fasting glucose alone becomes diagnostic of a problem.
This matters because insulin resistance is associated with a range of downstream conditions, including type 2 diabetes, non-alcoholic fatty liver disease, polycystic ovary syndrome, and cardiovascular risk (HOMA modeling in clinical practice). Identifying it early — when it is a metabolic pattern rather than an established diagnosis — provides meaningful opportunity to intervene.
HOMA-IR Normal Ranges and What Different Scores Indicate
HOMA-IR thresholds vary across published literature and differ somewhat by population, laboratory method, and clinical guideline. The following ranges represent commonly cited reference points; they are not universal diagnostic thresholds and should be interpreted by a qualified provider in the context of your full clinical picture.
Below 1.0: Optimal insulin sensitivity
A HOMA-IR score below 1.0 suggests high insulin sensitivity, meaning cells are responding efficiently to insulin signals and the pancreas is not compensating with excess secretion. This range is associated with favorable metabolic health in general population studies. Individuals who are lean, physically active, and metabolically healthy tend to cluster in this range.
1.0 to 2.0: Normal range
Most published clinical thresholds place the upper boundary of normal between 1.9 and 2.5, depending on the population studied. A score in the 1.0 to 2.0 range is generally consistent with adequate insulin sensitivity. Context matters: a score of 1.8 in someone with abdominal adiposity, elevated triglycerides, and a sedentary lifestyle warrants different consideration than the same score in someone without those factors.
2.0 to 3.0: Borderline insulin resistance
Scores in this range may indicate early or mild insulin resistance. Research published in the Journal of Clinical Lipidology in 2024 found that surrogate markers of insulin resistance, including HOMA-IR, are meaningfully predictive of metabolic syndrome in US adult populations, with increasing scores corresponding to rising metabolic risk. A borderline score is clinically useful precisely because it creates an opportunity to assess other markers and consider whether lifestyle modifications may be appropriate.
Above 3.0: Likely insulin resistance
A HOMA-IR above 3.0 is generally considered consistent with significant insulin resistance in most published studies, though the threshold used in clinical practice varies. Scores in this range are more consistently associated with elevated cardiovascular risk, fatty liver findings, and progressively impaired glucose regulation. A provider will consider this score in the context of fasting glucose, HbA1c, lipid patterns, and other clinical factors before drawing conclusions.
What Drives HOMA-IR Higher?
Abdominal adiposity
Visceral adipose tissue — fat stored around the abdominal organs rather than subcutaneously — is metabolically active in ways that promote insulin resistance. It secretes inflammatory cytokines and free fatty acids that interfere with insulin signaling in the liver and skeletal muscle (adipose tissue and insulin resistance in obesity). Abdominal adiposity is one of the strongest modifiable contributors to elevated HOMA-IR and often precedes overt glucose dysregulation by years. Waist circumference and waist-to-hip ratio are useful clinical correlates when interpreting a high HOMA-IR score.
Physical inactivity
Skeletal muscle is the primary site of insulin-stimulated glucose uptake, accounting for roughly 80% of whole-body glucose disposal during insulin stimulation (muscle glucose uptake and exercise physiology). Sedentary behavior reduces GLUT4 transporter expression in muscle, impairing this uptake and contributing to rising insulin secretion to compensate. Conversely, even acute bouts of moderate exercise improve insulin-stimulated glucose uptake for 24 to 48 hours, independently of changes in body weight.
Sleep deprivation and disruption
Sleep restriction is an underrecognized driver of insulin resistance. Even a single week of curtailed sleep (five hours per night in controlled studies) has been shown to measurably reduce insulin sensitivity in healthy adults (sleep restriction reduces insulin sensitivity). Circadian disruption — common in shift workers and individuals with irregular schedules — also impairs glucose regulation through mechanisms involving cortisol and growth hormone secretion timing. If HOMA-IR is elevated and lifestyle factors appear otherwise unremarkable, sleep quality and duration are worth evaluating.
Chronic low-grade inflammation
Inflammatory signaling, particularly through cytokines such as TNF-alpha and IL-6, directly interferes with insulin receptor signaling pathways (inflammatory mediators and insulin resistance). Elevated high-sensitivity CRP is a commonly used proxy for chronic low-grade inflammation and frequently co-occurs with elevated HOMA-IR. Identifying an inflammatory contributor to insulin resistance requires looking at the full biomarker picture rather than glucose or insulin in isolation.
Polycystic ovary syndrome (PCOS)
Insulin resistance is present in approximately 65 to 80 percent of women with PCOS, often independent of body mass index (insulin resistance markers in PCOS). It contributes to excess androgen production via insulin's direct stimulation of ovarian theca cells. In women with PCOS, HOMA-IR may be elevated even when fasting glucose is in the normal range, making it a more sensitive early indicator of metabolic abnormality than glucose alone in this population.
Non-alcoholic fatty liver disease (NAFLD)
The liver is both a target and a driver of insulin resistance. When hepatic insulin signaling is impaired, the liver continues to produce glucose despite elevated insulin levels (impaired suppression of hepatic glucose output). Elevated liver enzymes — particularly ALT — alongside a high HOMA-IR score can suggest hepatic insulin resistance and warrant evaluation for fatty liver. Superpower's GGT and ALT are relevant markers in this context.
Which Biomarkers to Assess Alongside HOMA-IR
HOMA-IR is calculated from two inputs, but the metabolic picture around insulin resistance is broader. Understanding your HOMA-IR score in context means assessing the associated markers that reflect different aspects of glucose regulation, lipid metabolism, and organ function.
- Fasting insulin — Baseline insulin secretion; HOMA-IR input
- Fasting glucose — Blood sugar regulation; HOMA-IR input
- HbA1c — Average blood glucose over 2–3 months
- Triglycerides — Elevated levels often accompany insulin resistance
- HDL cholesterol — Low HDL is a feature of insulin-resistant dyslipidemia
- hs-CRP — Inflammatory context for insulin resistance
Superpower's Metabolic Panel includes fasting insulin, an insulin resistance score, C-peptide, fructosamine, and metabolic hormones in a single draw, providing meaningful context for interpreting a HOMA-IR result. For a broader metabolic picture, Superpower's Baseline Blood Panel includes glucose, HbA1c, insulin, and lipid markers together.
What Affects HOMA-IR Accuracy?
Several factors can affect the reliability of a HOMA-IR result independently of true insulin sensitivity. Fasting duration matters: HOMA-IR requires a minimum 8-hour fast, as postprandial insulin levels remain elevated for hours after eating and will artificially inflate the score. Acute illness, recent intense exercise, and certain medications (particularly corticosteroids) can transiently affect both insulin and glucose levels. HOMA-IR also varies by the assay method used to measure insulin, meaning that scores from different laboratories are not always directly comparable.
A single HOMA-IR result is most useful as a starting point. Serial measurements — particularly tracking changes in response to dietary, activity, or other interventions — are often more informative than a single value, especially in borderline ranges.
When HOMA-IR is Worth Assessing
HOMA-IR is worth including in a metabolic assessment when fasting glucose is normal but other risk factors are present: family history of type 2 diabetes, abdominal adiposity, polycystic ovary syndrome, hypertension, non-alcoholic fatty liver disease, or unexplained fatigue and difficulty regulating weight. It is also useful for monitoring progress in individuals who are actively working to improve metabolic health, where changes in HOMA-IR may precede changes in fasting glucose or HbA1c.
HOMA-IR does not require a separate blood draw — it is calculated from fasting insulin and fasting glucose values that are routinely measured together. Adding it to a standard metabolic panel requires only that both inputs are collected in a fasted state.
Frequently Asked Questions
What is a normal HOMA-IR score?
Most clinical references place the normal range below 2.0 to 2.5, with optimal insulin sensitivity typically associated with scores below 1.0. Exact thresholds vary by published study and clinical context. A score should be interpreted by your provider alongside your full clinical picture rather than in isolation.
Can HOMA-IR be high if fasting glucose is normal?
Yes. This is a key feature of early insulin resistance. As the pancreas compensates for declining cellular insulin sensitivity by producing more insulin, fasting glucose can remain in the normal range while fasting insulin rises measurably. HOMA-IR captures this early compensatory pattern better than glucose alone.
What biomarkers affect HOMA-IR?
HOMA-IR is calculated from fasting insulin and fasting glucose. Anything that affects either of those values will affect the score. Incomplete fasting, acute stress, inflammation, corticosteroid use, and liver disease can all transiently alter the result. Consistent fasting conditions and repeat testing are important when using HOMA-IR for monitoring over time.
Is HOMA-IR the same as an insulin resistance test?
HOMA-IR is a calculated surrogate for insulin resistance rather than a direct physiological measurement. The gold standard for measuring insulin resistance is the hyperinsulinemic euglycemic clamp, which is used in research settings but not in routine clinical practice. HOMA-IR is the most widely used clinical approximation because it requires only fasting blood values. Other surrogate markers include the TyG index and the Cardio IQ Insulin Resistance Test.
How is HOMA-IR different from HbA1c?
HbA1c reflects average blood glucose over approximately 2 to 3 months and is primarily a measure of glycemic control. HOMA-IR reflects the relationship between insulin and glucose at a single fasting point and captures insulin secretory compensation. The two markers provide complementary information: HbA1c may remain normal even when HOMA-IR is elevated, because compensatory insulin secretion is successfully keeping blood sugar in range — for now.
This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making changes to your health routine. Superpower offers blood panels that include the biomarkers discussed in this article. Links to individual tests are provided for informational context.
.avif)